MARGINAL ZONE LYMPHOMA

Clinical trials for MARGINAL ZONE LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new MARGINAL ZONE LYMPHOMA trials appear

Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 31 Not yet recruiting 1 Not yet finished but already full! 14 Completed 8 Terminated 4

Immune cell army targets Hard-to-Treat lymphoma

Disease control Not yet recruiting

This early-phase trial tests a new treatment for people with B-cell non-Hodgkin lymphoma that has not responded to at least two prior therapies. Participants receive donor immune cells (NK cells) along with two antibody drugs (rituximab and tafasitamab) to help the body fight the…

Matched conditions: MARGINAL ZONE LYMPHOMA

Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control

Last updated May 13, 2026 16:01 UTC

MARGINAL ZONE LYMPHOMA

Get alerted when new MARGINAL ZONE LYMPHOMA trials appear

Immune cell army targets Hard-to-Treat lymphoma